Fresh Recalls

FDAClass II · Medical device · Recall Z-2286-2026 · Recalled June 10, 2026

Philips Azurion 5M12 recall — PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.

Agency report date: June 10, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Philips Azurion 5M12
Company / brand
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V
Lot / serial / date codes
UDI (01)00884838099227(21)88, (01)00884838099227(21)135, (01)00884838099227(21)63.
Distribution
US Nationwide distribution.
Agency product description and boundaries

Philips Azurion 5M12, Model Numbers: 722227 with Software release R2.2.0, R2.2.1, R2.2.3, R2.2.5 and R2.2.6 with the Roadmap Pro Software key

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: During the device phase of Roadmap Pro, a user may experience a dark image that is not clinically usable. The dark image may result after the user performs a pedal tap (shortly touching the footswitch pedal without generating an Xray image). The pedal tap may cause a dark image with the next fluoroscopy run.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Philips Azurion 5M12

3. Open the official notice or contact

Official recall ID
Z-2286-2026
Brand
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V
Classification
Class II
Units affected
3 units
Recall status
Ongoing

Affected products

Companies & origin

Recalling firm location
Best, Netherlands
Firm address
Veenpluis 6, N/A

Identifying details (verbatim from the notice)

Product codes / lots
UDI (01)00884838099227(21)88, (01)00884838099227(21)135, (01)00884838099227(21)63.
Distribution
US Nationwide distribution.
Firm notified the public via
Letter
FDA event ID
98977
Recall initiated
December 7, 2023
FDA classified
June 1, 2026
FDA report date
June 10, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page